AXA Private Equity provides additional financing to support the development of
Paris, October 30th, 2012. AXA Private Equity, the leading European diversified
private equity firm, announces today that it is providing €100 million of
additional financing to support the development of Ceva. The deal follows AXA
Private Equity’s first investment of €30 million in 2007 and highlights the
firm’s ability to offer innovative, tailor-made financing for companies.
Ceva is a global animal health company, which since becoming independent in
1999, has grown by more than 10% per year, well above the industry average,
thanks to an internal growth strategy focused on developing innovative products
combined with external growth achieved through build-ups. The management of
Ceva became the majority shareholders in the group in 2007, following the third
in a series of LBO’s supported by NiXEN, Euromezzanine and, in 2010, Sagard.
AXA Private Equity’s €100 million bond financing line reinforces its support to
Ceva and will complement the company’s existing bank financing. This flexible
approach will allow the company to enter the next phase of its development and
pursue its international build-up strategy.
Marc Prikazsky, Chairman & CEO of Ceva, said: “Our ability to successfully
incorporate new companies and products into a wider strategic vision has been a
key element for the growth of Ceva. Our results-based culture has allowed
numerous entrepreneurs to join us and retain their own management styles while
pursuing the same global vision as the group.”
Cécile Mayer-Levi, Co-Head of AXA Private Equity Private Debt, added: “We are
delighted to have provided this innovative form of financing as it is ideally
suited to Ceva’s existing capital structure and gives it the opportunity to
further its development internationally.”
about axa private equity
AXA Private Equity is a world leader in private equity, with assets of $30
billion managed or advised in Europe, North America and Asia. The company
offers its investors a wide choice of funds covering the full range of asset
classes: Funds of Funds (primary, early secondary and secondary), Direct Funds
including Infrastructure, Small and Mid Market Enterprise Capital, Innovation &
Growth, Co-Investment and Private Debt.
With offices in Paris, Frankfurt, New York, Singapore, Milan, London, Zurich,
Vienna and Luxembourg AXA Private Equity is committed to supporting companies
in their long term growth by providing access to its international network. AXA
Private Equity sets great store by the regularity and quality of its reporting
on the performance of its funds and the performance of the companies in its
portfolio, as a service to its investors.
AXA Private Equity, Global Investments the European way
Ceva Santé Animale is a global veterinary health company focused on the
research, development, production and marketing of vaccines and pharmaceutical
products for companion animals, livestock, swine and poultry. The group
employs over 3,000 people in 43 countries with forecasted sales of around €600
million in 2012.
Since 2007, the management is the majority shareholder alongside Nixen,
Euromezzanine and Sagard.
list of parties involved
Bond financing: AXA private Equity - Cécile Mayer-Lévi, Guillaume Chinardet,
Bank financing: Natixis & LCL – Godric Rosset
Management - Philippe du Mesnil, Marc Prikazsky, Pierre Revel-Mouroz, Valerie
Financial patners - Euromezzanine (François Carre), Nixen (Philippe Taranto)
and Sagard (Antoine Ernoult Dairaine
Bond financing: Willkie Farr & Gallagher - Paul Lombard, Igor Kukhta, Virginie
Bank financing: Gide – Eric Cartier-Million, Thomas Binet
Shareholders: Weil – David Aknin, David Malamed
AXA Private Equity
Tel: +44 207 3675 243
Tel: +44 207 3675 247
Head of Group Communication
Tel: +33 5 57 55 40 80
London EC2R 6AF
D: +44 (0)207 367 5240
M: +44 (0)7818 594 991
Press spacebar to pause and continue. Press esc to stop.